Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (29)
Sven Schnichels, Maximilian Schultheiss, Patricia Klemm, Matthias Blak, Thoralf Herrmann, Marion Melchinger, Karl-Ulrich Bartz-Schmidt, Marina Löscher, Günther Zeck, Martin Stehphan Spitzer & José Hurst. (2021) Cyclosporine A Protects Retinal Explants against Hypoxia. International Journal of Molecular Sciences 22:19, pages 10196.
Crossref
Crossref
Lepei Chen, Qingxiang Song, Yaoxing Chen, Shuang Meng, Mengna Zheng, Jialin Huang, Qian Zhang, Jiyao Jiang, Junfeng Feng, Hongzhuan Chen, Gan Jiang & Xiaoling Gao. (2020) Tailored Reconstituted Lipoprotein for Site-Specific and Mitochondria-Targeted Cyclosporine A Delivery to Treat Traumatic Brain Injury. ACS Nano 14:6, pages 6636-6648.
Crossref
Crossref
Konstantinos Palikaras & Nektarios Tavernarakis. (2020) Regulation and roles of mitophagy at synapses. Mechanisms of Ageing and Development 187, pages 111216.
Crossref
Crossref
Hyun Joon Lee, Jung Su Ryu & Parminder JS Vig. (2019) Current strategies for therapeutic drug delivery after traumatic CNS injury. Therapeutic Delivery 10:4, pages 251-263.
Crossref
Crossref
Shadab Kazmi, Anzar Abdul Mujeeb & Mohammad Owais. (2018) Cyclic undecapeptide Cyclosporin A mediated inhibition of amyloid synthesis: Implications in alleviation of amyloid induced neurotoxicity. Scientific Reports 8:1.
Crossref
Crossref
Aleksandra M. McGrath, Maria Brohlin, Rebecca Wiberg, Paul J. Kingham, Lev N. Novikov, Mikael Wiberg & Liudmila N. Novikova. (2018) Long-Term Effects of Fibrin Conduit with Human Mesenchymal Stem Cells and Immunosuppression after Peripheral Nerve Repair in a Xenogenic Model. Cell Medicine 10, pages 215517901876032.
Crossref
Crossref
Shamik Chakraborty, Brett E. Skolnick, Wayne M. Alves, Lawrence F. Marshall & Raj K. Narayan. 2018. Handbook of Neuroemergency Clinical Trials. Handbook of Neuroemergency Clinical Trials
85
109
.
Pengyu Pan, Xuan Zhang, Qiang Li, Hengli Zhao, Jie Qu, John H. Zhang, Xin Liu, Hua Feng & Yujie Chen. (2017) Cyclosporine A alleviated matrix metalloproteinase 9 associated blood-brain barrier disruption after subarachnoid hemorrhage in mice. Neuroscience Letters 649, pages 7-13.
Crossref
Crossref
Marloes J.A. Joosen, Stefanie M. Vester, Jouk Hamelink, Steven D. Klaassen & Roland M. van den Berg. (2016) Increasing nerve agent treatment efficacy by P-glycoprotein inhibition. Chemico-Biological Interactions 259, pages 115-121.
Crossref
Crossref
Shamik Chakraborty, Brett Skolnick & Raj K. Narayan. (2016) Neuroprotection Trials in Traumatic Brain Injury. Current Neurology and Neuroscience Reports 16:4.
Crossref
Crossref
Ying Deng-Bryant, Ryan Readnower, Lai Yee Leung, Frank Tortella & Deborah Shear. 2016. Injury Models of the Central Nervous System. Injury Models of the Central Nervous System
89
100
.
Annelie Handreck, Eva Maria Mall, Deborah Annina Elger, Laura Gey & Manuela Gernert. (2015) Different preparations, doses, and treatment regimens of cyclosporine A cause adverse effects but no robust changes in seizure thresholds in rats. Epilepsy Research 112, pages 1-17.
Crossref
Crossref
Yvette P. ConleyDavid O. OkonkwoSandra DeslouchesSheila AlexanderAva M. PuccioSue R. BeersDianxu Ren. (2014) Mitochondrial Polymorphisms Impact Outcomes after Severe Traumatic Brain Injury. Journal of Neurotrauma 31:1, pages 34-41.
Crossref
Crossref
L. Argaud & M. Cour. (2013) Protection tissulaire: une nouvelle pisteTissue protection: a new approach. Réanimation 23:S2, pages 342-351.
Crossref
Crossref
Irina S. BalanAndrew J. SaladinoBizhan AarabiRudolf J. CastellaniChristine WadeDeborah M. SteinHoward M. EisenbergHegang H. ChenGary Fiskum. (2013) Cellular Alterations in Human Traumatic Brain Injury: Changes in Mitochondrial Morphology Reflect Regional Levels of Injury Severity. Journal of Neurotrauma 30:5, pages 367-381.
Crossref
Crossref
Karl Henrik Johannes Ehinger, Magnus Joakim Hansson, Fredrik Sjövall & Eskil Elmér. (2012) Bioequivalence and Tolerability Assessment of a Novel Intravenous Ciclosporin Lipid Emulsion Compared to Branded Ciclosporin in Cremophor® EL. Clinical Drug Investigation 33:1, pages 25-34.
Crossref
Crossref
Hiroyuki Uchino, Kiyoshi Hatakeyama, Saori Morota, Tadashi Tanoue, Takahisa Nishiyama, Daiki Usui, Chisato Taguchi, Morika Suzuki, Magnus J. Hansson & Eskil Elmér. 2013. Brain Edema XV. Brain Edema XV
311
315
.
Seungmoon Jung, Hyunwoo Yang, Byung Sun Kim, Kon Chu, Sang Kun Lee & Daejong Jeon. (2012) The immunosuppressant cyclosporin A inhibits recurrent seizures in an experimental model of temporal lobe epilepsy. Neuroscience Letters 529:2, pages 133-138.
Crossref
Crossref
Kevin W. McConeghy, Jimmi Hatton, Lindsey Hughes & Aaron M. Cook. (2012) A Review of Neuroprotection Pharmacology and Therapies in Patients with Acute Traumatic Brain Injury. CNS Drugs 26:7, pages 613-636.
Crossref
Crossref
Niklas Marklund & Lars Hillered. (2011) Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?. British Journal of Pharmacology 164:4, pages 1207-1229.
Crossref
Crossref
Ryan D. ReadnowerJignesh D. PandyaMelanie L. McEwenJames R. PaulyJoseph E. SpringerPatrick G. Sullivan. (2011) Post-Injury Administration of the Mitochondrial Permeability Transition Pore Inhibitor, NIM811, Is Neuroprotective and Improves Cognition after Traumatic Brain Injury in Rats. Journal of Neurotrauma 28:9, pages 1845-1853.
Crossref
Crossref
Marloes J.A. Joosen, Marcel J. van der Schans, Christian G.M. van Dijk, Willem C. Kuijpers, Heleen M. Wortelboer & Herman P.M. van Helden. (2011) Increasing oxime efficacy by blood–brain barrier modulation. Toxicology Letters 206:1, pages 67-71.
Crossref
Crossref
Xiao-Hui Luo, Wu-Jun Xue, Pu-Xun Tian, Xiao-Ming Ding, Hang Yan, He-Li Xiang & Yang Li. (2011) The clinical value of enzyme-multiplied immunoassay technique monitoring the plasma concentrations of cyclosporine A after renal transplantation. Journal of Pharmaceutical Analysis 1:2, pages 139-142.
Crossref
Crossref
Patrick G. SullivanAndrea H. SebastianEdward D. Hall. (2011) Therapeutic Window Analysis of the Neuroprotective Effects of Cyclosporine A after Traumatic Brain Injury. Journal of Neurotrauma 28:2, pages 311-318.
Crossref
Crossref
Magnus J. HanssonSaori MorotaLi ChenNagahisa MatsuyamaYoshiaki SuzukiSatoshi NakajimaTadashi TanoueAkibumi OmiFutoshi ShibasakiMotohide ShimazuYukio IkedaHiroyuki UchinoEskil Elmér. (2011) Cyclophilin D-Sensitive Mitochondrial Permeability Transition in Adult Human Brain and Liver Mitochondria. Journal of Neurotrauma 28:1, pages 143-153.
Crossref
Crossref
P. Trindade, R. Antonioli-Santos, A.C. Teixeira, B. Lanzillotta-Mattos, A.C.F. Melibeu, P. Campello-Costa, R. Linden & C.A. Serfaty. (2011) Evidence for a role of calcineurin in the development of retinocollicular fine topography. Neuroscience Letters 487:1, pages 47-52.
Crossref
Crossref
P. A. Williams, J. E. Morgan & M. Votruba. (2010) Opa1 deficiency in a mouse model of dominant optic atrophy leads to retinal ganglion cell dendropathy. Brain 133:10, pages 2942-2951.
Crossref
Crossref
Ibolja Cernak & Linda J Noble-Haeusslein. (2009) Traumatic Brain Injury: An Overview of Pathobiology with Emphasis on Military Populations. Journal of Cerebral Blood Flow & Metabolism 30:2, pages 255-266.
Crossref
Crossref
Jacyntha A. Sterling. (2009) Recent Publications on Medications and Pharmacy. Hospital Pharmacy 44:9, pages 822-828.
Crossref
Crossref